Federal Bank Announces Robust Audited Financial Results for Q4 and Fiscal Year 2025-26
Federal Bank has reported a strong financial performance for the quarter and year ended March 31, 2026. The bank achieved a standalone net…
Vakrangee Limited Strong Financial Performance for Fiscal Year Ending March 2026
Vakrangee Limited has reported audited financial results for the quarter and year ended March 31, 2026. The company demonstrated consistent…
Sterlite Technologies Limited Reports Resilient FY’26 Performance with Strong AI Data Centre Growth
Sterlite Technologies Limited (STL) reported a strong financial performance for the year ended March 31, 2026. The company achieved revenues…
Titan Company Board Meeting Scheduled for May 8, 2026
Titan Company Limited has announced that a meeting of its Board of Directors is scheduled for Friday, May 8, 2026. The primary agenda for this…
Thyrocare Technologies Board Meeting Scheduled to Approve Financial Results
Thyrocare Technologies has announced that its Board of Directors will convene on May 07, 2026. The primary agenda for this meeting includes…
Lloyds Metals and Energy Limited Committee Approves ₹750 Crore NCD Issuance
Lloyds Metals and Energy Limited has announced that its Committee of Board has approved the issuance of Non-Convertible Debentures (NCDs) on a…
Granules India Strong Fiscal Year 2026 Performance with Final Dividend Recommendation
Granules India Limited has reported its financial results for the quarter and year ended March 31, 2026. The company achieved a consolidated…
CESC Limited Board Meeting Scheduled for May 6, 2026
CESC Limited has formally announced that its Board of Directors will convene on Wednesday, May 6, 2026. The primary objective of this meeting…
Tata Motors Passenger Vehicles Limited Board Meeting Scheduled for Q4 FY2026 Results
Tata Motors Passenger Vehicles Limited has announced that its Board of Directors will convene on May 14, 2026, to review and approve the…
Piramal Pharma Limited Q4 & Annual FY2026 Financial Results and Leadership Appointments
Piramal Pharma Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company reported standalone…